{"id":"W2163238468","doi":"10.1016/j.amjcard.2014.05.060","title":"Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials)","year":2014,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"Amgen","keywords":"Alirocumab; PCSK9; Medicine; Placebo; Internal medicine; Lipoprotein(a); Kexin; Evolocumab; Lipoprotein; Dosing; Endocrinology; Gastroenterology; Cholesterol; LDL receptor; Apolipoprotein A1; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006382401,0.002721969,0.006376053,0.0008458968,0.000374416,0.001740399,0.0007958986,0.001976793,0.003714089],"category_scores_gemma":[0.006080688,0.001169048,0.009938103,0.0006751366,0.000818587,0.001738654,0.0006422208,0.003155774,0.0005686144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008288133,"about_ca_system_score_gemma":0.0007700499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001419023,"about_ca_topic_score_gemma":0.00353874,"domain_scores_codex":[0.9968174,0.001861317,0.0002594543,0.000521392,0.000206516,0.0003339536],"domain_scores_gemma":[0.9965935,0.001794755,0.0007526915,0.0002896862,0.0002197095,0.0003496192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.943661,0.0007380578,0.003049575,0.00126916,0.02811218,0.00009036545,0.00004334314,0.001066723,0.002895207,0.00004321927,0.001052944,0.01797816],"study_design_scores_gemma":[0.6096514,0.189071,0.08767595,0.0003141988,0.1033696,0.0004367197,0.0001476935,0.00247673,0.003312237,0.0004125892,0.002944791,0.0001871124],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9505538,0.04020097,0.0009181935,0.000624745,0.0005371732,0.000527377,0.003381589,0.0002265706,0.003029604],"genre_scores_gemma":[0.9908222,0.004626257,0.0005975849,0.0004837982,0.0002938016,0.0002047724,0.001446943,0.0000357981,0.00148885],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006382401,"threshold_uncertainty_score":0.03375381,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01740808616805861,"score_gpt":0.3518448448536979,"score_spread":0.3344367586856393,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}